Mr Shkreli made headlines in September 2015 when his firm Turing Pharmaceuticals increased the price of a drug used to treat people with weakened immune systems caused by HIV by 5,000 percent. That meant the drug went from a price of $13.50 per pill to a staggering $750.
Shkreli defended the price hike:
“If there was a company that was selling an Aston Martin at the price of a bicycle, and we buy that company and we ask to charge Toyota prices, I don’t think that that should be a crime.”
On October 22, 2015, Imprimis Pharmaceuticals said it would begin selling a very similar, but not an identical drug, for $1 per pill, to further compound Shkreli’s and his company’s extreme position.
Read more in the UK’s Independent article.
The lesson, of course, is not to put money before people, son!